Literature DB >> 1155460

Genetics of acheiropodia (the handless and footless families of Brazil). VI. Formal genetic analysis.

A Freire-Maia, N Freire-Maia, N E Morton, E S Azevêdo, A Quelce-Salgado.   

Abstract

A genetic analysis is presented of data from 22 Brazilian sibships with cases of acheiropodia (the handless and footless families of Brazil). Segregation analysis performed using a 16K CDC 3100 computer showed a segregation frequency of .245 +/- .040, which is close to the expected value of .25. No sporadic cases were detected. The ascertainment of the probands was through multiple incomplete selection (pi = .55 +/- .07). The data are consistent with the hypothesis of an extremely rare autosomal recessive gene as the etiological factor in acheiropodia. Prevalence is estimated as 29 +/- 4, which is the same as the number of high risk cases; gene frequency equals .0009 +/- .0005, and the incidence at birth is 4 times 10(-6) by the indirect method or 7 times 10(-6) by the direct method. The frequency of heterozygotes at birth is assumed to be 0.18% (450 times the frequency of affected). Population size is approximately 10 million, and the number of founders on a unique-mutation hypothesis is estimated as about 500. All these estimates are first approximations and must be accepted with caution.

Entities:  

Mesh:

Year:  1975        PMID: 1155460      PMCID: PMC1762812     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  7 in total

1.  ESTIMATION OF PREVALENCE UNDER INCOMPLETE SELECTION.

Authors:  I BARRAI; M P MI; N E MORTON; N YASUDA
Journal:  Am J Hum Genet       Date:  1965-05       Impact factor: 11.025

2.  Genetic tests under incomplete ascertainment.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1959-03       Impact factor: 11.025

3.  Inbreeding in Brazil.

Authors:  N FREIRE-MAIA
Journal:  Am J Hum Genet       Date:  1957-12       Impact factor: 11.025

4.  Segregation analysis in human genetics.

Authors:  N E MORTON
Journal:  Science       Date:  1958-01-10       Impact factor: 47.728

5.  The handless and footless families of Brazil.

Authors:  A Freire-Maia
Journal:  Lancet       Date:  1970-10-03       Impact factor: 79.321

6.  The handless and footless families of Brazil.

Authors:  A Freire-Maia
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

7.  A radiological and genetic investigation of acheiropody in a kindred including six cases.

Authors:  S P Toledo; P H Saldanha
Journal:  J Genet Hum       Date:  1969-05
  7 in total
  5 in total

1.  Acheiropodia is caused by a genomic deletion in C7orf2, the human orthologue of the Lmbr1 gene.

Authors:  P Ianakiev; M J Daly; S P Toledo; M G Cavalcanti; J C Neto; E L Silveira; A Freire-Maia; P Heutink; M W Kilpatrick; P Tsipouras
Journal:  Am J Hum Genet       Date:  2000-11-22       Impact factor: 11.025

2.  Age, area, and acheiropody.

Authors:  N E Morton; C A Barbosa
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

3.  A minimalist approach to gene mapping: locating the gene for acheiropodia, by homozygosity analysis.

Authors:  M A Escamilla; M C DeMille; E Benavides; E Roche; L Almasy; S Pittman; J Hauser; D F Lew; N B Freimer; M R Whittle
Journal:  Am J Hum Genet       Date:  2000-04-25       Impact factor: 11.025

4.  Deletion of CTCF sites in the SHH locus alters enhancer-promoter interactions and leads to acheiropodia.

Authors:  Aki Ushiki; Yichi Zhang; Chenling Xiong; Jingjing Zhao; Ilias Georgakopoulos-Soares; Lauren Kane; Kirsty Jamieson; Michael J Bamshad; Deborah A Nickerson; Yin Shen; Laura A Lettice; Elizabeth Lemos Silveira-Lucas; Florence Petit; Nadav Ahituv
Journal:  Nat Commun       Date:  2021-04-16       Impact factor: 14.919

5.  Genetics and genomics in Brazil: a promising future.

Authors:  Maria Rita Passos-Bueno; Debora Bertola; Dafne Dain Gandelman Horovitz; Victor Evangelista de Faria Ferraz; Luciano Abreu Brito
Journal:  Mol Genet Genomic Med       Date:  2014-07       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.